Page 7 - Lipocine Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lipocine daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lipocine Daily Today - Breaking & Trending Today

StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report issued on Monday morning. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 4.3 % Shares of NASDAQ LPCN opened at $3.82 on Monday. Lipocine has a twelve month low of $3.30 and a twelve […] ....

Lipocine Company Profile , Renaissance Technologies , Goldman Sachs Group Inc , Lipocine Inc , Millennium Management , Blackrock Inc , Free Report , Trading Down , Get Free Report , Street Corp , Goldman Sachs Group , Sachs Group , Lipocine Daily , Nasdaq Lpcn , Initiated Coverage , Stocknews Com ,

Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews.com

Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackrock Inc , Renaissance Technologies , Lipocine Company Profile , Goldman Sachs Group Inc , Millennium Management , Lipocine Inc , Get Free Report , Street Corp , Goldman Sachs Group , Sachs Group , Lipocine Daily ,

Lipocine (NASDAQ:LPCN) Earns Buy Rating from Analysts at StockNews.com

Lipocine (NASDAQ:LPCN) Earns Buy Rating from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lipocine Inc , Renaissance Technologies , Ep Wealth Advisors , Blackrock Inc , Topco Ltd , Free Report , Trading Down , Get Free Report , Street Corp , Lipocine Daily ,

Lipocine (NASDAQ:LPCN) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Saturday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Lipocine stock opened at $4.16 on Friday. The stock has a market cap of $22.11 million, a price-to-earnings ratio of -1.75 and […] ....

Maheshv Patel , Millennium Management , Securities Exchange Commission , Goldman Sachs Group Inc , Blackrock Inc , Lipocine Inc , Renaissance Technologies , Free Report , Exchange Commission , Street Corp , Goldman Sachs Group , Sachs Group , Get Free Report , Lipocine Daily , Nasdaq Lpcn , Initiated Coverage , Stocknews Com ,

Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 1.4 % Shares of LPCN opened at $5.08 on Friday. Lipocine has a 12 month low of $3.30 and […] ....

Maheshv Patel , Lipocine Inc , Renaissance Technologies , Goldman Sachs Group Inc , Lipocine Company Profile , Blackrock Inc , Millennium Management , Free Report , Get Free Report , Street Corp , Goldman Sachs Group , Sachs Group , Lipocine Daily , Nasdaq Lpcn , Initiated Coverage , Stocknews Com ,